Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Amgen Inc Transaction History
Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P.
- $653 Million
- Q3 2024
A detailed history of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. transactions in Amgen Inc stock. As of the latest transaction made, Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. holds 3,974 shares of AMGN stock, worth $1.13 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,974
Previous 4,029
1.37%
Holding current value
$1.13 Million
Previous $1.26 Million
1.75%
% of portfolio
0.2%
Previous 0.27%
Shares
4 transactions
Others Institutions Holding AMGN
# of Institutions
3,119Shares Held
410MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$14.9 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.31 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.17 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.04 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $152B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...